All the following is found in Primary Sjogren syndrome exceptaEUR’
**Core Concept**
Primary Sjogren syndrome is a chronic autoimmune disorder characterized by lymphocytic infiltration of the **exocrine glands**, particularly the **salivary** and **lacrimal glands**. This leads to **dry mouth (xerostomia)** and **dry eyes (xerophthalmia)**. The underlying pathophysiology involves a complex interplay of **immune cells**, **cytokines**, and **autoantibodies**.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the common features of Primary Sjogren syndrome. It typically presents with **sicca symptoms**, such as dry eyes and mouth, and can be associated with **autoantibodies** like **anti-SSA/Ro** and **anti-SSB/La**. The condition can also involve **extraglandular manifestations**, including **arthritis**, **skin rash**, and **neuropathy**.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, it's challenging to provide a detailed explanation. However, common incorrect options might include **systemic lupus erythematosus (SLE)**-specific features, as Primary Sjogren syndrome can be distinguished from SLE.
**Option B:** Similarly, without the specific option, it's difficult to provide a detailed explanation. However, features of **rheumatoid arthritis** or other autoimmune disorders might be incorrect options.
**Option C:** Again, without the specific option, it's challenging to provide a detailed explanation. However, **organ-specific autoimmune disorders** like **Hashimoto's thyroiditis** might be incorrect options.
**Option D:** Without knowing the specific option, it's difficult to provide a detailed explanation.
**Clinical Pearl / High-Yield Fact**
Primary Sjogren syndrome is often associated with an increased risk of **lymphoma**, particularly **non-Hodgkin lymphoma**. Patients with Primary Sjogren syndrome should be monitored for signs of lymphoma, such as **lymphadenopathy** or **splenomegaly**.
**Correct Answer:** Correct Answer: D.